ArticleOpen forum infectious diseases2022

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India.

Jeffrey A Tornheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.